Found 10 matching trials
Long Acting GnRH Antagonist in PCOS Women Undergoing IVF N/A PCOS is a common endocrinopathy affecting 5-10% of women in their reproduct...
Show More Learn More & Join Trial
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy PHASE2 In April 2011, the United States Food and Drug Administration (FDA) approve...
Show More Location
Northwestern University, Feinberg School of Medicine
Learn More & Join Trial
The COSMYC Trial (COmbined Suppression of MYC) PHASE2 This research is being done to determine if receiving the combination of te...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer PHASE2 Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Show More Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) N/A The prostate gland is a clinically important male accessory sex gland and v...
Show More Status
Active Not Recruiting
Location
Prince of Wales Hospital
Learn More & Join Trial
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function NA Complaints about memory and thinking are common in women as they go through...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response PHASE2 The objective of this study is to determine the safety and clinical effects...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer PHASE1 This research study is trying to determine the safety and efficacy of the c...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) PHASE2 The purpose of this study is to describe the rate of 3-year progression fre...
Show More Location
GU Research Network / Urology Cancer Center
Learn More & Join Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease PHASE3 The purpose of this trial is to test if a marketed drug for advanced prosta...
Show More Location
Urology Center of Alabama PC
Learn More & Join Trial